Introduction {#S1}
============

In 1969, myalgic encephalomyelitis (ME/CFS) was introduced into the eighth edition of the international classification of diseases of the WHO (ICD-8: code 323) and had been classified as a disease of the central nervous system ([@B3]). Chronic fatigue syndrome (CFS) was added to the ICD-9. Because of a substantial overlap of clinical features and the absence of a diagnostic biomarker that discriminates between these two, many refer to this disease as ME/CFS. Studies in the 1990s highlighted the association between ME/CFS and various forms of orthostatic intolerance (OI), such as orthostatic hypotension (OH) and postural orthostatic tachycardia syndrome (POTS) ([@B2]; [@B11]; [@B16]; [@B29]; [@B31]). Although neglected in the Fukuda criteria for CFS ([@B18]) OI is one of several qualifying features in the international consensus criteria (ICC) for ME ([@B5]) and a cardinal feature in the United States ([@B19]).

Impairments in cognitive functioning are among the most frequently reported symptoms of ME/CFS. Patients describe these cognitive symptoms as equally debilitating compared to the physical symptoms that accompany this disease. During a survey of ME/CFS patients, the descriptions of the memory and concentration problems were variously described as: brain fog, confusion, disorientation, hard to concentrate, can't focus, inability to process information, inability to multi-task, and short-term memory loss. In more severe cases, patients have difficulty completing tasks that require sustained attention and report problems performing even relatively simple activities such as watching television ([@B15]). Patients report slowed information processing, poor memory function compared to the time before the disease started, and overall mental fatigue or slowed thinking ([@B21]; [@B10]). One of the best studied aspects of ME/CFS is cognition. In a meta-analysis of 50 studies using a total of 80 cognitive tests with 79 different scores, of 8 cognitive domains described, reaction time and attention were the only two domains with a moderate to large, significant difference between ME/CFS patients and healthy controls ([@B9]).

One of the tests used for investigating working memory processes is the N-back test. The N-back test is a continuous performance measure where stimulus sequences of visual, auditory, or olfactory stimuli are presented and the subject is required to indicate whether the actual stimulus matches the one presented "n" trials previously: for a visual 2-back only one other picture between the two same stimuli is required, and for a visual 3-back two other pictures between the two same stimuli are required ([@B26]). Slowed information processing is the most commonly reported objective neurocognitive symptom in ME/CFS patients ([@B19]; [@B23]; [@B8]; [@B32]). As the N-back test is dependent on processing information speed in the working memory, the test has been used to measure cognitive function in ME/CFS patient groups ([@B26]; [@B9]; [@B30]; [@B25]).

As one of the symptoms in OI syndromes is impaired concentration due to cerebral underperfusion ([@B22]), we hypothesized that cognitive deterioration in ME/CFS patients would be present after orthostatic stress induced by the head-up tilt test (HUT). For this purpose the raw reaction times and percentage correct answers of the 2- and 3-back test were analyzed pre-and post-HUT in ME/CFS patients. Moreover, cognitive dysfunction is part of the post-exertional malaise and the onset of the post-exertional malaise is variably reported in literature, from immediately after the stressor up until days later ([@B28]; [@B38]; [@B35]; [@B37]). Therefore, we assessed cognitive decline immediately after HUT.

Materials and Methods {#S2}
=====================

Eligible Participants {#S2.SS1}
---------------------

Individuals were eligible for this study if they were evaluated between November 2015 and June 2018, met the criteria for ME/CFS, and underwent a HUT to evaluate a clinical suspicion of OI. OI was defined as described in the IOM report: "Orthostatic intolerance is defined as a clinical condition in which symptoms worsen upon assuming and maintaining upright posture and are ameliorated (although not necessarily abolished) by recumbency" \[(IOM) 2015\]. Symptoms of orthostatic intolerance sought in the history of patients "are those caused primarily by (1) cerebral underperfusion (such as light- headedness, near-syncope or syncope, impaired concentration, headaches, and dimming or blurring of vision), or (2) sympathetic nervous system activation (such as forceful beating of the heart, palpitations, tremulousness, and chest pain. Other common signs and symptoms of orthostatic intolerance are fatigue, a feeling of weakness, intolerance of low-impact exercise, nausea, abdominal pain, facial pallor, nervousness, and shortness of breath." We included all those in whom a complete set of N-back tests were available. ME/CFS was considered present if participants met both the 1994 International Chronic Fatigue Syndrome Study Group criteria for CFS ([@B18]) and the 2011 international consensus definition of ME ([@B5]), taking the exclusion criteria into account.

The study was carried out in accordance with the Declaration of Helsinki. The use of clinical data for descriptive studies was approved by the ethics committee of the Slotervaart Hospital, the Netherlands (P1450). All patients gave informed consent to analyze their data.

Head-Up Tilt Table Test {#S2.SS2}
-----------------------

The HUT was performed as described previously ([@B34]). Briefly, testing was conducted at least 3 h after a light meal. Participants were encouraged to ingest an ample amount of fluid on the day of the procedure, but did not drink fluids in the 2 h before the test. Participants were studied in a climate-controlled room where the temperatures ranged from 22--24°C. Individuals were studied in the supine position for 15 min, and for 30 min in the upright position (70-degrees). The test was ended after 30 min, at the request of the patient, or if the individual developed syncope or pre-syncope.

Heart rate (HR), systolic and diastolic blood pressures (SBP and DBP) were continuously recorded by finger plethysmography using the Nexfin device (BMeye, Amsterdam, Netherlands) ([@B14]; [@B24]). An independent radio-controlled clock was used to mark the starting time of HR and BP recordings as well as the time of the start of tilting. HR and BP data were extracted from the Nexfin device and imported into an Excel spreadsheet. Supine HR and BP data were calculated from the last minute data before tilting. Upright HR and BP data were calculated from the last minute data of the upright position. HR and BP responses during the HUT were classified according to consensus guidelines, like orthostatic hypotension (a decrease of over 20 mmHg in systolic blood pressure and over 30 mmHg in case of a systolic blood pressure over 140 mmHg, or a decrease of 10 mmHg in diastolic blood pressure) and postural orthostatic tachycardia syndrome (a sustained increase of at least 30 bpm within 10 min, without a significant decrease in BP) ([@B17]; [@B27]). Nasal prongs were placed to measure expired carbon dioxide (CO~2~) concentrations. For the tilt testing component, individuals being treated with medication that could alter HR or BP (beta-adrenergic antagonists, midodrine, fludrocortisone, desmopressin, pyridostigmine bromide, anti-hypertensive medications, or ivabradine) were excluded from this analysis. Individuals being treated with selective serotonin reuptake inhibitors or serotonin norepinephrine reuptake inhibitors continued to take these medications.

N-Back Cognitive Test {#S2.SS3}
---------------------

We used a visual N-back test available online: <http://cognitivefun.net/test/4>. The visual N-back test is composed of stimuli of 10 different simple colored cartoons randomly shown on the screen. The stimulus interval was approximately 1900 m/s and each stimulus was shown for approximately 1500 m/s. All participating ME/CFS patients were required to log in at the website and perform several training sessions of the visual 2- and 3-back tests before they underwent HUT. Patients were excluded when they performed each test less than 10 times because of the learning curve of the test. All tests before and after HUT were executed on the same computer system with the same right-handed mouse pointer. Fifteen minutes before the start of the HUT, the patients were asked to perform the visual 2- and 3-back test. The software shows the correct or incorrect answers on the screen, just to the right of the presented cartoon. To avoid distracting the participants this part of the screen was blinded during data acquisition. Within 5 min after finalization of the HUT, the visual 2- and 3-back tests were repeated. From the tests the percentage of correct responses and the raw reaction time in m/s were noted.

Statistical Analysis {#S2.SS4}
--------------------

Data were analyzed using the statistical package of Graphpad Prism version 8.2.4 (Graphpad software, La Jolla, CA, United States). All continuous data were tested for normal distribution using the Kolmogorov--Smirnov test, and presented as means (SD) or as median with the IQR where appropriate. Nominal data were compared using the Chi-square test (in a 3 × 2 table). For continuous data groups were compared using the paired or unpaired *t*-test where appropriate. Within group comparison was done by the two-way analysis of variance (ANOVA). Where significant, results were then explored further using the *post hoc* Holm--Sidak test. A *p*-value of \<0.05 was considered to be statistically significant.

Results {#S3}
=======

We evaluated 385 individuals with ME/CFS and a clinical suspicion of OI at the Stichting CardioZorg during the study period. We excluded those with another type of orthostatic stress testing (seated test or active standing test: *n* = 16), those who had not completed training on the test due to the absence of a laptop or computer at home (*n* = 118), those who were left-handed (*n* = 9), and those who had not trained sufficiently as per protocol (*n* = 111). Three others were excluded because of pre- syncope and not being able to perform the N-back tests within 5 min after HUT (*n* = 3). None of the patients used HR or BP lowering drugs before the HUT. This left 128 participants to be analyzed. Demographic data of the patients not analyzed were comparable to the demographic data of the patients included in the analysis (data not shown).

[Table 1](#T1){ref-type="table"} shows the demographic characteristics of the study population. During history taking at the first visit, 84% percent reported memory and concentration problems (108/128). Based on the history taking at the first visit, ME/CFS severity was graded as mild in 49 (38%), moderate in 55 (43%), and severe in 24 (19%) according to the ME criteria ([@B5]).

###### 

Demographic data and hemodynamic HUT results of the study population.

  **Demographic data**                               
  -------------------------------------------------- ------------------------
  Number of patients                                 128
  Females                                            116/128 (91%)
  Height in cm                                       172 (8)
  Weight in kg                                       75 (17)
  Age in years                                       39 (11)
  Median duration of ME/CFS (IQR) in years           9 (5--16)
  Disease severity: mild/moderate/severe\*           49/55/24 (38%/43%/19%)
  Fibromyalgia present                               65/128 (51%)
  Self-reported cognitive problems                   108/128 (84%)
  SSRI use                                           34/128 (27%)
  **Hemodynamic responses during HUT**               
  Normal heart rate/blood pressure response          59/128 (46%)
  Postural orthostatic tachycardia syndrome (POTS)   49/128 (38%)
  Orthostatic hypotension (OH)                       20/128 (16%)

Data represent mean (SD). HUT: head-up tilt test; SSRI: selective serotonin reuptake inhibitors. \*Disease severity grading according to classification of ICC (

Carruthers et al., 2011

).

[Table 2](#T2){ref-type="table"} shows the hemodynamic results of the HUT in ME/CFS patients with normal heart rate/blood pressure response (norm HR/BP) (*n* = 59), in ME/CFS patients with postural orthostatic tachycardia syndrome (POTS) (*n* = 49) and ME/CFS patients with orthostatic hypotension (OH) (*n* = 20). By definition, the HR increase in the POTS group and the BP decline in the OH group are significantly different from the two other groups. The 2-way ANOVA showed a significant interaction effect between the three predefined hemodynamic profiles and the results of heart rate, systolic blood pressure, diastolic blood pressure and end-tidal CO~2~ (*p*-value varying between 0.0038 and \<0.0001). *Post hoc* analysis results are presented in the table.

###### 

Hemodynamic responses during HUT of the study population.

                               **Group 1 NormHR/BP**   **Group 2 POTS**   **Group 3 OH**   **2-way ANOVA and *post hoc* Holm-Sidak test**
  ---------------------------- ----------------------- ------------------ ---------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Number of patients           59                      49                 20               
  Male/female                  8/51                    3/46               1/19             Chi square 0.32 (3 × 2 table)
  HR supine (bpm)              74 (11)                 80 (15)            68 (9)           *F* (2, 250) = 11.10; *p* \< 0.0001. *Post hoc* tests: pre-HUT 1 vs. 2 *p* = 0.052 1 vs. 3 *p* = 0.096 and 2 vs. 3 *p* = 0.0038 and post-HUT 1 vs. 2 *p* \< 0.0001; 1 vs. 3 *p* = 0.58 and 2 vs. 3 *p* \< 0.0001
  End of tilt HR (bpm)         91 (11)                 118 (18)           89 (18)          
  SBP supine (mmHg)            137 (17)                132 (12)           142 (11)         *F* (2, 250) = 13.37; *p* \< 0.0001. *Post hoc* tests: pre-HUT 1 vs. 2 *p* = 0.18 1 vs. 3 *p* = 0.21 and 2 vs. 3 *p* = 0.046 and post-HUT 1 vs. 2 *p* = 0.008; 1 vs. 3 *p* \< 0.0001 and 2 vs. 3 *p* = 0.0076
  End of tilt SBP (mmHg)       131 (18)                123 (15)           111 (15)         
  DBP supine (mmHg)            80 (8)                  79 (7)             78 (6)           *F* (2, 250) = 9.008; *p* = 0.0002. *Post hoc* tests: pre-HUT 1 vs. 2 *p* = 0.79 1 vs. 3 *p* = 0.74 and 2 vs. 3 *p* = 0.79 and post-HUT 1 vs. 2 *p* = 1.0; 1 vs. 3 *p* \< 0.0001 and 2 vs. 3 *p* \< 0.0001
  End of tilt DBP (mmHg)       85 (9)                  85 (9)             73 (11)          
  EtCO~2~ supine (mmHg)        37 (3)                  36 (3)             37 (3)           *F* (2, 250) = 5.69; *p* = 0.0038. *Post hoc* tests: pre-HUT 1 vs. 2 *p* = 0.56 1 vs. 3 *p* = 1.0 and 2 vs. 3 *p* = 0.63 and post-HUT 1 vs. 2 *p* \< 0.0001; 1 vs. 3 *p* = 0.078 and 2 vs. 3 *p* = 0.0.0013
  End of tilt EtCO~2~ (mmHg)   32 (5)                  26 (6)             30 (5)           

Data represent mean (SD). All upright data are end of tilt test data. DBP: diastolic blood pressure; EtCO

2

: end-tidal CO

2

; HR: heart rate; NormHR/BP: normal heart rate/blood pressure response; OH: orthostatic hypotension; POTS: postural orthostatic tachycardia syndrome; SBP: systolic blood pressure.

[Table 3](#T3){ref-type="table"} shows the N back results between the groups in the ME/CFS patients with a normal heart rate and blood pressure response, the ME/CFS patients with POTS and the ME/CFS patients with orthostatic hypotension. All N-back results (percent correct responses and raw reaction times for both 2-back and 3-back) were compared pre- and post-HUT. All parameters changed highly significantly different (*p* all \<0.0001). The 2-way ANOVA showed no significant within group differences and no significant interaction effect between the three hemodynamic profiles and the pre- and post-HUT N-back results for both 2-back and 3-back.

###### 

N-back results pre- and post-HUT in ME/CFS patients with norm HR/BP, POTS and orthostatic hypotension.

  **N-back results**             **Group 1 Norm HR/BP**   **Group 2 POTS**   **Group 3 OH**   **2-way ANOVA and *post hoc* Holm--Sidak test**
  ------------------------------ ------------------------ ------------------ ---------------- -------------------------------------------------
  2 Back test                    *n* = 59                 *n* = 49           *n* = 20         
  \% Correct response pre-HUT    80 (15)                  76 (19)            73 (19)          *F* (2, 250) = 0.18; *i* = 0.83.
  \% Correct response post-HUT   67 (20)                  59 (23)            58 (20)          
  Raw reaction time pre-HUT      774 (192)                793 (191)          790 (190)        *F* (2, 250) = 0.038; *p* = 0.96.
  Raw reaction time post-HUT     941 (243)                939 (223)          945 (247)        
  3 Back test                                                                                 
  \% Correct response pre-HUT    60 (17)                  57 (18)            52 (13)          *F* (2, 250) = 0.081; *p* = 0.92.
  \% Correct response post-HUT   44 (17)                  41 (18)            34 (12)          
  Raw reaction time pre-HUT      945 (171)                939 (166)          966 (180)        *F* (2, 250) = 0.14; *p* = 0.87.
  Raw reaction time post-HUT     1100 (175)               1085 (190)         1142 (143)       

Data represent mean (SD). Raw reaction time is given in m/s. HUT: head-up tilt test; Norm HR/BP: normal heart rate and blood pressure response of the head-up tilt test; POTS: postural orthostatic tachycardia syndrome.

For all patients the percentage of correct responses on 2- and 3 back test before and after HUT showed a significant reduction: in the 2-back from 77(18) to 62(21) and in the 3-back from 57(17) to 41(17) (both *p* \< 0.0001). [Figure 1](#F1){ref-type="fig"} shows the percentage of correct responses of 2- and 3-back tests before and after HUT in the three different hemodynamic groups: normal heart rate and blood pressure response ([Figure 1A](#F1){ref-type="fig"}), POTS ([Figure 1B](#F1){ref-type="fig"}) and orthostatic hypotension ([Figure 1C](#F1){ref-type="fig"}). In all three groups a significant reduction of the percent correct responses was found (all *p* \< 0.0001). For all patients the raw reaction times on 2- and 3-back tests before and after HUT showed a significant increase: the 2-back from 783(190) to 941(234) m/s and the 3-back from 950(170) to 1102(176) m/s (both *p*: \< 0.0001). [Figure 2](#F2){ref-type="fig"} shows the raw reaction time of 2- and 3-back tests before and after HUT in the three different hemodynamic groups: normal heart rate and blood pressure response ([Figure 2A](#F2){ref-type="fig"}), POTS ([Figure 2B](#F2){ref-type="fig"}) and orthostatic hypotension ([Figure 2C](#F2){ref-type="fig"}). In all three groups a significant increase in raw reaction time was found (*p* ranging between 0.0002 and \<0.0001).

![Shows the percentage of correct responses on 2-back and 3-back test before and after head-up-tilt testing for the three HUT results: normal heart rate and blood pressure **(A)**, POTS **(B)** and orthostatic hypotension **(C)**. HUT: head-up tilt test; Norm HR/BP response: normal heart rate and blood pressure response.](fnins-14-00688-g001){#F1}

![Shows the raw reaction time on 2-back an 3-back test before and after head-up-tilt testing for the three HUT results: normal heart rate and blood pressure **(A)**, POTS **(B)**, and orthostatic hypotension **(C)**. HUT: head-up tilt test; Norm HR/BP response: normal heart rate and blood pressure response.](fnins-14-00688-g002){#F2}

[Table 4](#T4){ref-type="table"} shows the N-back results of the patients with mild, moderate, and severe disease defined by the ME criteria. All N-back results (percent correct responses and raw reaction times for both 2-back and 3-back) were compared pre- and post-HUT. All parameters changed highly significantly different (*p* all \<0.0001). The 2-way ANOVA showed no significant within group differences and no significant interaction effect between the three disease severity groups and the pre- and post-HUT N-back results for both 2-back and 3-back. No significant differences were found comparing the three groups. [Figure 3](#F3){ref-type="fig"} shows the percentage of correct responses of 2- and 3-back tests before and after HUT in ME/CFS patients with mild disease ([Figure 3A](#F3){ref-type="fig"}), moderate disease ([Figure 3B](#F3){ref-type="fig"}) and severe disease ([Figure 3C](#F3){ref-type="fig"}). In all three groups a significant reduction of the percent correct responses was found (all *p* \< 0.0001). [Figure 4](#F4){ref-type="fig"} shows the raw reaction time of 2- and 3-back tests before and after HUT in ME/CFS patients with mild disease ([Figure 4A](#F4){ref-type="fig"}), moderate disease ([Figure 4B](#F4){ref-type="fig"}) and severe disease ([Figure 4C](#F4){ref-type="fig"}). In all three groups a significant reduction of the percent correct responses was found (all *p* \< 0.0001). The 2-way ANOVA showed no significant within group differences and no significant interaction effect between the three hemodynamic profiles and the three severity groups. In patients with or without fibromyalgia no significant differences were found between the two groups (data not shown). In patients with or without SSRI's no significant differences were found between the two groups (data not shown).

###### 

N-back results pre- and post-HUT in ME/CFS patients with a mild, a moderate or a severe degree of ME/CFS.

  **N-back results**             **Group 1 mild**   **Group 2 moderate**   **Group 3 severe**   **2-way ANOVA and *post hoc* Holm--Sidak test**
  ------------------------------ ------------------ ---------------------- -------------------- -------------------------------------------------
  2 Back test                    *n* = 49           *n* = 55               *n* = 24             
  \% Correct response pre-HUT    81 (17)            75 (18)                74 (17)              *F* (2, 250) = 0.018; *p* = 0.98.
  \% Correct response post-HUT   67 (22)            60 (17)                60 (20)              
  Raw reaction time pre-HUT      742 (185)          803 (203)              823 (160)            *F* (2, 250) = 0.41; *p* = 0.66.
  Raw reaction time post-HUT     907 (262)          973 (228)              936 (181)            
  3 Back test                                                                                   
  \% Correct response pre-HUT    60 (17)            56 (16)                56 (17)              *F* (2, 250) = 0.022; *p* = 0.98.
  \% Correct response post-HUT   43 (17)            40 (18)                40 (14)              
  Raw reaction time pre-HUT      936 (177)          973 (168)              924 (158)            *F* (2, 250) = 0.0081; *p* = 0.99.
  Raw reaction time post-HUT     1086 (169)         1125 (176)             1081 (189)           

Data represent mean (SD). Raw reaction time is in m/s. HUT: head-up tilt test.

![Shows the percentage of correct responses on 2-back and 3-back test before and after head-up-tilt testing, for the three disease severity grading of ME/CFS: patients with mild disease **(A)**, moderate disease **(B)**, and severe disease **(C)**. HUT: head-up tilt test.](fnins-14-00688-g003){#F3}

![Shows the raw reaction time on 2-back an 3-back test before and after head-up-tilt testing, for the three disease severity grading of ME/CFS: patients with mild disease **(A)**, moderate disease **(B)**, and severe disease **(C)**. HUT: head-up tilt test.](fnins-14-00688-g004){#F4}

Discussion {#S4}
==========

The main finding of this study is that in adults with ME/CFS, orthostatic stress testing is followed by a deterioration of cognitive function as measured by a visual 2- and 3-back memory test. This deterioration of cognitive function was independent of the hemodynamic outcome of the HUT test. There was no difference in correct answers or raw reaction time between patients with no abnormalities in heart rate and blood pressure, POTS or orthostatic hypotension. A relation with the decline in cerebral blood flow during HUT -- irrespective of heart rate and blood pressure changes -- as consequence of the orthostatic stress may explain the deterioration in working memory. Compared to pre-HUT values, the number of correct answers diminished and the raw reaction time increased post-HUT. These findings are strengthened by the relatively large sample size compared to other studies of cognitive function in ME/CFS.

We elected to use the N-back test because Cockshell and Matthias showed in a meta-analysis that six out of the eight cognitive domains studied were significantly different in ME/CFS patients compared to healthy controls ([@B9]). The N-back test assesses four of these six domains: reaction time, attention, memory, and motor functioning. Moreover, responses of the N-back test in healthy controls are correlated with activation in several brain regions as shown by neuro-imaging ([@B26]).

Several studies have used the N-back test in evaluating ME/CFS patients ([@B6]; [@B30]; [@B25]). The study of [@B6] investigated 17 ME/CFS patients and 12 healthy controls using a verbal N-back test administered while participants were supine. No differences between the ME/CFS patients and controls were found in the accuracy and the reaction times of the 2- and 3-back tests ([@B6]). Nevertheless, trend analyses of task load, as detected by functional MRI imaging, demonstrated statistically significant differences in brain activation between the two groups with increasing task demands. [@B30] confirmed the absence of supine differences in the proportion of correct answers and reaction times between ME/CFS patients with co-morbid POTS and healthy controls. In contrast, with upright positioning using various degrees of tilting, Stewart et al., found a progressive worsening in the number of correct answers and an increase in reaction times in ME/CFS/POTS patients (*n* = 25) in contrast to controls (*n* = 20). They hypothesized that the cognitive impairment was caused by a reduction in cerebral blood flow as was demonstrated using transcranial Doppler flow velocities in ME/CFS/POTS patients and controls during HUT ([@B30]).

The current study shows that the cognitive abnormalities in ME/CFS are not restricted to those with POTS. We have previously shown that ME/CFS patients with a normal HR and BP response to a 30 min HUT nonetheless have a significant reduction in cerebral blood flow (CBF) as measured by extracranial Doppler imaging of the internal carotid and vertebral arteries ([@B33]). Healthy individuals develop a 7% CBF reduction, whereas those with ME/CFS develop a 28% reduction overall, 24% in those with normal HR/BP responses and 29% in those with POTS or orthostatic hypotension. Although the earlier study confirmed less of a decline in CBF in those with a normal HR and BP response to HUT, the current study identified no significant differences in 2-back and 3-back correct answers or reaction times between those with normal HR/BP and those with POTS. This suggests that there may be an important threshold of reduced CBF that is associated with the declines in cognitive performance.

Previous studies have described deterioration of the number of correct responses and an increase in reaction times in ME/CFS patients during HUT. Our study shows that similar findings are observed shortly after HUT (start of the N-back tests within 5 min), suggesting that the effects of orthostatic stress persist for a period of time following HUT. The IOM report mentions: "Clinicians who evaluate those with orthostatic intolerance recognize that individuals with ME/CFS can develop an exacerbation of their typical symptoms not just during the head-up tilt test but for several days afterward. The committee's literature search did not identify any publications describing this observation more formally" \[(IOM) 2015\]. Previous studies have quantitatively demonstrated a decrease in cognitive functioning after physical exertion in ME/CFS patients ([@B1]; [@B20]). Whether physical stress exerts the same cognitive dysfunction as orthostatic stress needs to be studied in the future.

Post exertional malaise (PEM) is an exacerbation of some or all of an individual's ME/CFS symptoms that occurs after physical or cognitive exertion and leads to a reduction in functional ability ([@B4]). Some studies have shown that PEM may occur quickly, within 30 min of exertion ([@B1]) while others have found that patients may experience a worsening of symptoms 1--7 days after exertion ([@B28]; [@B38]; [@B35]; [@B37]). The results of our study suggest that post exertional malaise may start immediately after completion of the orthostatic stress test. Future studies will have to address whether the exacerbation in cognitive performance extends beyond 24 h.

[@B7] studied the relation between disease severity in ME/CFS and cognitive function using the California verbal learning test (CVLT). Patients reporting less activity were found to have worse test results than patients with relatively more activity. Using the 2- and 3-back test and grading severity according to the ME criteria, we could not replicate their findings (see [Table 4](#T4){ref-type="table"} and [Figures 3](#F3){ref-type="fig"}, [4](#F4){ref-type="fig"}; [@B5]). The differences between these studies might be explained by differences in tests, severity grading and sample size.

Limitations {#S4.SS1}
-----------

No comparison with healthy controls was available. However, in the study of the N-back test in healthy controls during HUT was not different from the supine N-back test [@B25]. Whether cognitive function results before and after HUT or before and after another stressor can be extrapolated to daily life remains also to be studied. In the present study patients performed the N-back tests while seated. There are suggestions that differences between ME/CFS patients and controls might be due to performing tests seated while no differences might be present in the supine position ([@B13]; [@B12]; [@B36]; [@B30]). This hypothesis needs to be tested. We only tested ME/CFS patients with a clinical suspicion of OI who underwent HUT. The N-back tests pre- and post-HUT in ME/CFS patients without OI symptoms need to be evaluated. We did not evaluate the length of time that cognitive testing remains abnormal following HUT, but this deserves further study. We used an on-line, readily available version of the N-back test. We are not aware of a comparison of this test with other versions of the N-back test. Although different forms of the N-back test might have other stimulus exposure times, resulting in a different percentage of correct answers, in the present study patients were their own comparison, which validates the outcomes of a worse performance post-HUT.

Conclusion {#S5}
==========

Using a visual 2- and 3-back test, this study shows that working memory is impaired shortly after orthostatic stress testing in ME/CFS patients, extending observations from previous small studies that working memory is impaired during orthostatic stress. Our results are consistent with the observation that PEM can start immediately after an orthostatic stress.
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